Previous close | 158.18 |
Open | 158.57 |
Bid | 156.78 x 800 |
Ask | 156.75 x 1000 |
Day's range | 156.50 - 158.69 |
52-week range | 144.95 - 175.97 |
Volume | |
Avg. volume | 6,907,121 |
Market cap | 377.757B |
Beta (5Y monthly) | 0.53 |
PE ratio (TTM) | 30.15 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 4.76 (3.04%) |
Ex-dividend date | 16 Feb 2024 |
1y target est | N/A |
Nvidia said Monday that it was partnering with Johnson & Johnson MedTech to use the power of AI to help doctors perform surgery. J&J MedTech is in 80% of the world’s operating rooms and trains more than 140,000 healthcare professionals each year, the companies said. The company believes Nvidia’s AI technology could improve data analytics from devices, patient, and other surgery data.
Johnson & Johnson (JNJ) closed the most recent trading day at $156.76, moving -0.9% from the previous trading session.
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.